NGM Bio Announces Initiation of Phase 1/1b Clinical Trial of NGM831 for the Treatment of

Retrieved on: 2022-03-31 20:45:32

Tags for this article:

Click the tags to see associated articles and topics

NGM Bio Announces Initiation of Phase 1/1b Clinical Trial of NGM831 for the Treatment of. View article details on hiswai:

Excerpt

... own immune systems to fight tumors by shifting myeloid cells from a suppressive state to a stimulatory state; the design of NGM Bio's clinical ...

Article found on: www.bakersfield.com

View Original Article